One of the most important advancements in diabetes since insulin has come from the unfailing love of a father for his very ill daughter.
In December of 1984, Trina became a diabetic at age 2. She subsequently was extremely brittle with multiple hospitalizations, even though her mother was a pediatric RN and PHN. Some children are like that, chronically ill with poor chances at living a normal life or living to middle age.
Her father, Ford Gilbert, was not going to accept that eventuality. After becoming the volunteer of the year for the American Diabetes Association, Northern California, he decided to reduce his practice of law and learn how to use an engineering background to help his little girl. He attended medical school classes, started a non-profit research institute and began the quest. Starting with the idea of a new pump which took into account more diabetes factors, he wanted to use his fluid handling experience to deliver Trina’s insulin in a better way, and keep her from frequent hospitalizations and ER visits, and a disease which robs children of a future.
But just controlling insulin was not enough -- the device had to do more than just help control blood sugar, because blood sugar is only a symptom of the core problem for all diabetes (type 1 & 2), which is the inability to burn carbohydrates and thus the dependence on free fatty acids and lipid metabolism. In other words, he realized that to effectively treat diabetes, he had to build a system which would “turn back on” Trina’s ability to metabolize carbohydrates.
His quest took him around the world, to Europe, (Miles Labs), Japan (AHS), and Australia. After an invalid concept and approach by a university professor, he designed a new system which actually mimics the way a pancreas interacts, now known as the Artificial Pancreas Treatment®. This system is now being launched in many countries and domestically. The regulatory approvals, including FDA approval and clinical trials, have taken all these years and over $40 million. And, even though he started with nothing and carried the project though development and now to commercialization by clinics, it has been a labor of family love. Many friends of Ford have dug deeply into their pockets to fund the project.
By the Artificial Pancreas Treatment® stimulation of the liver, in the same manner as a non-diabetic pancreas, people with both type 1 and type 2 diabetes can regain the ability to burn sugars and stop the processes that damage organs through too much free fatty acids and lipid use. Amazingly, his system was mimicking a non-diabetic pancreas before it became known by publications in 2002 that almost all insulin is delivered in non-diabetics in discrete boluses.
The Artificial Pancreas Treatment® merely restores proper cellular energy adenosine triphosphate (ATP) to all cells of a diabetic, and their organs and whole bodies heal themselves naturally (DNA never forgets). Now patients with the complications of diabetes can stop and reverse their disease, as the treatment works on heart, kidney, eye, nerve disease and even un-healing wounds.
After 200,000 treatments, and no adverse reactions, the Artificial Pancreas Treatment® is currently established in several states and expanding throughout the USA. Patients uniformly reverse their diabetic complications! This uniform addressing of all diabetes complications is how we know that the core problem, improper metabolism, is effectively being treated by the Artificial Pancreas Treatment®.
Today at age 33 Trina is well, with none of her former symptoms. Trina is the proud mother of five healthy children.